![Murat Kalayoglu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Murat Kalayoglu
Nessuna posizione attualmente
Patrimonio netto: 123 M $ in data 31/05/2024
Profilo
Murat V.
Kalayoglu is the founder of Cartesian Therapeutics, Inc. which was founded in 2016, where he held the title of President & Chief Executive Officer until 2023.
He is also the founder of HealthHonors, Topokine Therapeutics, Inc. Dr. Kalayoglu's current job is as a Director at Cartesian Therapeutics, Inc. Dr. Kalayoglu holds an MBA degree from Massachusetts Institute of Technology and a doctorate degree from the University of Wisconsin.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
19.88% | 18/04/2024 | 3 537 331 ( 19.88% ) | 123 M $ | 31/05/2024 |
Posizioni attive di Murat Kalayoglu
Società | Posizione | Inizio |
---|
Precedenti posizioni note di Murat Kalayoglu
Società | Posizione | Fine |
---|---|---|
Cartesian Therapeutics, Inc.
![]() Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | Amministratore Delegato | 01/11/2023 |
HealthHonors
![]() HealthHonors Miscellaneous Commercial ServicesCommercial Services HealthHonors provides behavioral economics consulting services. The company is based in Braintree, MA. The company was founded by Murat V. Kalayoglu, Michael S. Singer. HealthHonors was acquired by Tivity Health, Inc., part of Stonepoint Capital LLC from June 28, 2022 on October 14, 2009 for $14.70 million. | Fondatore | - |
Topokine Therapeutics, Inc.
![]() Topokine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Topokine Therapeutics, Inc. develops therapies for dermatology and medical aesthetics. Its product, the XAF5 Gel, reduces excess subcutaneous fat. The XAF5 is an adipomodulatory compound that inhibits adipocytes by engaging a cell-surface receptor, resulting in down-regulation of key adipocyte transcription factors. The company was founded in 2010 and is headquartered in Madison, NJ. | Fondatore | - |
Formazione di Murat Kalayoglu
University of Wisconsin | Doctorate Degree |
Massachusetts Institute of Technology | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Topokine Therapeutics, Inc.
![]() Topokine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Topokine Therapeutics, Inc. develops therapies for dermatology and medical aesthetics. Its product, the XAF5 Gel, reduces excess subcutaneous fat. The XAF5 is an adipomodulatory compound that inhibits adipocytes by engaging a cell-surface receptor, resulting in down-regulation of key adipocyte transcription factors. The company was founded in 2010 and is headquartered in Madison, NJ. | Health Technology |
HealthHonors
![]() HealthHonors Miscellaneous Commercial ServicesCommercial Services HealthHonors provides behavioral economics consulting services. The company is based in Braintree, MA. The company was founded by Murat V. Kalayoglu, Michael S. Singer. HealthHonors was acquired by Tivity Health, Inc., part of Stonepoint Capital LLC from June 28, 2022 on October 14, 2009 for $14.70 million. | Commercial Services |
Cartesian Therapeutics, Inc.
![]() Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | Commercial Services |
- Borsa valori
- Insiders
- Murat Kalayoglu